As the House Energy and Commerce Committee prepares to craft comprehensive legislation to address the nation’s opioid epidemic, AHA today urged the committee to report legislation to align 42 CFR Part 2 with the Health Insurance Portability and Accountability Act. “Congress must amend this law, which impedes the sharing of critical patient information that is necessary to deliver the most effective and efficient care,” AHA Executive Vice President Tom Nickels said in a letter to committee leaders. “Applying the same requirements to all patient information − whether behavioral or medical − would support the appropriate information sharing essential for clinical care coordination and population health improvement, while safeguarding patient information from unwarranted disclosure. H.R. 3545 would achieve these goals and we, therefore, urge the Committee to report this important legislation as introduced.” Tomorrow afternoon, the committee will convene a two-day hearing on more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies.
 

Related News Articles

Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
Headline
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic. The…
Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Department of Health and Human Services Tuesday reminded health care providers that HIPAA privacy rules bar them from giving media and film crews access to…
Headline
Members of the Partnership to Amend 42 CFR Part 2, including the AHA, today urged the Department of Health and Human Services to issue a rule as soon as…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…